Xiekui Cui

🦉 Tumor genes can matter most through the cells next door. Most CRISPR screens ask which genes make a cancer cell survive. This preprint asks a more interesting question: which tumor genes determine what the surrounding immune cells actually do? Using match-seq, a viral barcode system that records cellular proximity, the authors coupled spatial relationships to CRISPR perturbations and single-cell RNA-seq in mouse tumors. The striking result is that different tumor genes rewired different immune neighborhoods. Tgfb1 loss recruited CD8 T-cell/macrophage activity; Traf7 loss favored a CD4 response; Nectin3 loss triggered NK-cell immunity. More importantly, Tgfb1 and Nectin3 barely affected cancer-cell fitness in the pooled screen, yet deleting them across the tumor suppressed growth. That exposes a blind spot in conventional functional genomics: a target can look dispensable when fitness is measured cell by cell, while being crucial because it controls the immune ecosystem around those cells. The biology is still preclinical and match-seq itself needs broader validation, but the conceptual shift is useful—some of the better immunotherapy targets may be hiding not in tumor-intrinsic dependency maps, but in the spatial relationships those screens usually destroy. #immunotherapy #CAR_T #CRISPR 👉biorxiv.org/content/10.64898…